Atlas Trials

A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India

Clinical trial NCT05375929 · COMPLETED

Trial details

NCT number
NCT05375929
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2022-07-16
Primary completion
2023-06-09
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.